BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Euro-Mediterranean Institute for Quality and Safety in Health Services - ECPv4.9.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Euro-Mediterranean Institute for Quality and Safety in Health Services
X-ORIGINAL-URL:https://eiqsh.eu
X-WR-CALDESC:Euro-Mediterranean Institute for Quality and Safety in Health Services - Εκδηλώσεις
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20210303T133000
DTEND;TZID=Europe/Helsinki:20210303T183000
DTSTAMP:20260502T092942
CREATED:20210301T130422Z
LAST-MODIFIED:20210301T130422Z
UID:5499-1614778200-1614796200@eiqsh.eu
SUMMARY:Global consultation on COVID-19 therapeutics
DESCRIPTION:WHO will host a Global consultation on COVID-19 therapeutics to discuss knowledge gaps and research priorities\, with the following objectives to outline: \n\nthe main priority research questions of importance to public health and a targeted research agenda for 2021 that identifies knowledge gaps and prioritization pathways for therapeutics in clinical development phase and those being repurposed\, including combinations\, and research priorities for new COVID therapeutics; and\nadditional steps to ensure further international collaboration supports the coordinated implementation of key research.\n\nThe webinar will be convened on Wednesday\, 3 March 2021\, 13:30 – 18:30 Central European Time (CET). The proposed agenda will be provided in advance. \nPlease register on the link below to receive your connection details. \nhttps://who-e.zoom.us/webinar/register/WN_CNfywAEiTEWgqA_nEcjeow \n
URL:https://eiqsh.eu/event/global-consultation-on-covid-19-therapeutics/
LOCATION:ONLINE
ATTACH;FMTTYPE=image/png:https://eiqsh.eu/wp-content/uploads/2021/01/sdsdd.png
END:VEVENT
END:VCALENDAR